Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

BO-653: an antioxidant with potential in restenosis

July 3, 1998

LXR Biotechnology implements strategic development plan

July 2, 1998

Ferulinolol, a highly selective beta1-adrenoceptor blocker

July 2, 1998

Na+/H+ exchange inhibitors from Kanebo useful for cardiac ischemia

July 1, 1998

Direct myocardial effects of OPC-18790

July 1, 1998

European trial of Bextra initiated

June 30, 1998

Canadian launch for improved antihypertensive medication

June 24, 1998

Hoechst Marion Roussel claims Na+/H+ exchange inhibitors with excellent antiarrhythmic activity

June 22, 1998

Shock reported following substitution of mibefradil with other calcium channel blockers

June 19, 1998

Cypros begins pivotal phase III trial with Cordox

June 19, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...